Semaphorin 4B (SEMA4b) has been shown to play a substantial role in the invasion of non-small cell lung cancer (NSCLC). However, the regulation mechanism of SEMA4b is largely elusive. Here, we reported significant decrease in SEMA4b level and significant increase in MMP9 level in NSCLC compared with the adjacent normal tissue from the same patient. We thus used two human NSCLC lines, A549 and Calu-3, to examine whether SEMA4b may affect the expression of MMP9 in NSCLC. We found that overexpression of SEMA4b significantly decreased MMP9 level, while SEMA4b inhibition significantly increased MMP9 level. The adapted MMP9 levels affected the potential of NSCLC invasiveness correspondingly. To define the signal transduction cascades downstream of SEMA4b for regulation of MMP9 expression, we inhibited PI3K, ERK/MAPK, or JNK signaling pathway in SEMA4b knockout NSCLC and found that only inhibition of PI3K signaling pathway significantly decreased MMP9 activation. Our data thus suggest that SEMA4b may activate PI3K signaling pathway to promote MMP9 expression, which subsequently increases metastasis of NSCLC. Our study thus highlights SEMA4b as a novel therapeutic target for NSCLC.
SEMA4b Non-small cell lung cancer MMP9 ERK/MAPK PI3K JNK
This is a preview of subscription content, log in to check access.
This work is financially supported by Wujieping Medical Foundation No: 320.6750.14060.
Conflict of interest
The authors have declared that no competing interests exist.
Pei J, Lou Y, Zhong R, Han B. Mmp9 activation triggered by epidermal growth factor induced foxo1 nuclear exclusion in non-small cell lung cancer. Tumour Biol. 2014;35(7):6673–8.PubMedCrossRefGoogle Scholar
Song H, Tian Z, Qin Y, Yao G, Fu S, Geng J. Astrocyte elevated gene-1 activates mmp9 to increase invasiveness of colorectal cancer. Tumour Biol. 2014;35(7):6679–85.PubMedCrossRefGoogle Scholar
Wang F, Xiao W, Sun J, Han D, Zhu Y. Mirna-181c inhibits egfr-signaling-dependent mmp9 activation via suppressing akt phosphorylation in glioblastoma. Tumour Biol. 2014. doi:10.1007/s13277-014-2131-6.
Jian H, Liu B, Zhang J. Hypoxia and hypoxia-inducible factor 1 repress sema4b expression to promote non-small cell lung cancer invasion. Tumour Biol. 2014;35:4949–55.PubMedCrossRefGoogle Scholar
Nagai H, Sugito N, Matsubara H, Tatematsu Y, Hida T, Sekido Y, et al. Clcp1 interacts with semaphorin 4b and regulates motility of lung cancer cells. Oncogene. 2007;26:4025–31.PubMedCrossRefGoogle Scholar
Basile JR, Afkhami T, Gutkind JS. Semaphorin 4d/plexin-b1 induces endothelial cell migration through the activation of pyk2, src, and the phosphatidylinositol 3-kinase-akt pathway. Mol Cell Biol. 2005;25:6889–98.PubMedCentralPubMedCrossRefGoogle Scholar
Aghajanian H, Choi C, Ho VC, Gupta M, Singh MK, Epstein JA. Semaphorin 3d and semaphorin 3e direct endothelial motility through distinct molecular signaling pathways. J Biol Chem. 2014;289:17971–9.PubMedCrossRefGoogle Scholar
Pan G, Zhu Z, Huang J, Yang C, Yang Y, Wang Y, et al. Semaphorin 5a promotes gastric cancer invasion/metastasis via urokinase-type plasminogen activator/phosphoinositide 3-kinase/protein kinase b. Dig Dis Sci. 2013;58:2197–204.PubMedCentralPubMedCrossRefGoogle Scholar
Gallo G. Semaphorin 3a inhibits erm protein phosphorylation in growth cone filopodia through inactivation of pi3k. Dev Neurobiol. 2008;68:926–33.PubMedCrossRefGoogle Scholar
Atwal JK, Singh KK, Tessier-Lavigne M, Miller FD, Kaplan DR. Semaphorin 3f antagonizes neurotrophin-induced phosphatidylinositol 3-kinase and mitogen-activated protein kinase kinase signaling: a mechanism for growth cone collapse. J Neurosci. 2003;23:7602–9.PubMedGoogle Scholar
Wen H, Lei Y, Eun SY, Ting JP. Plexin-a4-semaphorin 3a signaling is required for toll-like receptor- and sepsis-induced cytokine storm. J Exp Med. 2010;207:2943–57.PubMedCentralPubMedCrossRefGoogle Scholar
Burkhardt C, Muller M, Badde A, Garner CC, Gundelfinger ED, Puschel AW. Semaphorin 4b interacts with the post-synaptic density protein psd-95/sap90 and is recruited to synapses through a c-terminal pdz-binding motif. FEBS Lett. 2005;579:3821–8.PubMedCrossRefGoogle Scholar